Product Details for ANDA 210441
HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)
100MG
Marketing Status: Prescription
200MG
Marketing Status: Prescription
300MG
Marketing Status: Prescription
400MG
Marketing Status: Prescription
100MG
Marketing Status: Prescription
Active Ingredient: HYDROXYCHLOROQUINE SULFATE
Proprietary Name: HYDROXYCHLOROQUINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210441
Product Number: 002
Approval Date: Sep 19, 2022
Applicant Holder Full Name: APPCO PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)
Proprietary Name: HYDROXYCHLOROQUINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210441
Product Number: 002
Approval Date: Sep 19, 2022
Applicant Holder Full Name: APPCO PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
200MG
Marketing Status: Prescription
Active Ingredient: HYDROXYCHLOROQUINE SULFATE
Proprietary Name: HYDROXYCHLOROQUINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210441
Product Number: 001
Approval Date: May 1, 2018
Applicant Holder Full Name: APPCO PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)
Proprietary Name: HYDROXYCHLOROQUINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210441
Product Number: 001
Approval Date: May 1, 2018
Applicant Holder Full Name: APPCO PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
300MG
Marketing Status: Prescription
Active Ingredient: HYDROXYCHLOROQUINE SULFATE
Proprietary Name: HYDROXYCHLOROQUINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210441
Product Number: 003
Approval Date: Sep 19, 2022
Applicant Holder Full Name: APPCO PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)
Proprietary Name: HYDROXYCHLOROQUINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210441
Product Number: 003
Approval Date: Sep 19, 2022
Applicant Holder Full Name: APPCO PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
400MG
Marketing Status: Prescription
Active Ingredient: HYDROXYCHLOROQUINE SULFATE
Proprietary Name: HYDROXYCHLOROQUINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210441
Product Number: 004
Approval Date: Sep 19, 2022
Applicant Holder Full Name: APPCO PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: HYDROXYCHLOROQUINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A210441
Product Number: 004
Approval Date: Sep 19, 2022
Applicant Holder Full Name: APPCO PHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information